CDRD Trademark

Trademark Overview


On Wednesday, February 28, 2018, a trademark application was filed for CDRD with the United States Patent and Trademark Office. The USPTO has given the CDRD trademark a serial number of 87815377. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, August 24, 2021. This trademark is owned by Centre for Drug Research and Development. The CDRD trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing specialized pharmaceutical development and commercialization expertise and infrastructure to identify, validate and advance promising drug discoveries, and to transform such discoveries into commercially viable investment opportunities and into new therapies for patients, namely, (a) providing scientific research information and drug discovery information in the field of pharmaceuticals, (b) providing scientific consulting services in the field of pharmaceutical research, development and commercialization, (c) providing education and training services in the field of pharmaceutical research, development and commercialization, (d) providing pharmaceutical research, inspection, evaluation, testing and development services, (e) providing laboratory research services, (f) providing laboratory and office facilities, apparatus, devices, solutions and instruments, (g) providing technical advice and support services, (h) promoting collaboration within the scientific, research and med...
cdrd

General Information


Serial Number87815377
Word MarkCDRD
Filing DateWednesday, February 28, 2018
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, August 24, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Indication of Colors claimedThe color(s) dark blue, light blue, dark grey, mid grey and light grey is/are claimed as a feature of the mark.
Description of MarkThe mark consists of a graphical element consisting of repeating geometric figures being solid hexagon shapes to form a fanciful hexagon. For the first outer row going in a clockwise direction starting at the top, the first four hexagons are mid grey, the next four hexagons are light blue, the next four hexagons are dark blue, the next four hexagons are mid grey, the next four hexagons are light blue and the next four hexagons are dark blue. For the second outer row going in a clockwise direction from the top, the first three hexagon shapes are mid grey, the next three hexagon shapes are light blue, the next three hexagon shapes are dark blue, the next three hexagon shapes are mid grey, the next three hexagon shapes are light blue and the next three hexagon shapes are dark blue. For the third outer row going in a clockwise direction from the top, the first two hexagon shapes are mid grey, the next two hexagon shapes are light blue, the next two hexagon shapes are dark blue, the next two hexagon shapes are mid grey, the next two hexagon shapes are light blue and the next two hexagon shapes are dark blue. For the fourth outer row going in a clockwise direction from the top, the first hexagon shape is mid grey, the next hexagon shape is light blue, the next hexagon shape is dark blue, the next hexagon shape is mid grey, the next hexagon shape is light blue and the next hexagon shape is dark blue. The sole interior hexagon shape is light grey. "CDRD" is in dark grey.
Goods and ServicesProviding specialized pharmaceutical development and commercialization expertise and infrastructure to identify, validate and advance promising drug discoveries, and to transform such discoveries into commercially viable investment opportunities and into new therapies for patients, namely, (a) providing scientific research information and drug discovery information in the field of pharmaceuticals, (b) providing scientific consulting services in the field of pharmaceutical research, development and commercialization, (c) providing education and training services in the field of pharmaceutical research, development and commercialization, (d) providing pharmaceutical research, inspection, evaluation, testing and development services, (e) providing laboratory research services, (f) providing laboratory and office facilities, apparatus, devices, solutions and instruments, (g) providing technical advice and support services, (h) promoting collaboration within the scientific, research and medical communities to achieve advances in the field of pharmaceuticals, and (i) providing consulting services in the innovation and commercialization of new pharmaceuticals, namely, sourcing investments and partners, analyzing and advancing projects, assisting in commercialization through intellectual property consulting and advice, assisting in executing commercial transactions and corporate structuring

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, March 8, 2018
Primary Code042
First Use Anywhere DateTuesday, October 31, 2017
First Use In Commerce DateTuesday, October 31, 2017

Trademark Owner History


Party NameCentre for Drug Research and Development
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressVancouver, BC V6T1Z3
CA

Trademark Events


Event DateEvent Description
Wednesday, August 25, 2021ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, August 24, 2021ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, February 8, 2021NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, February 8, 2021INQUIRY TO SUSPENSION E-MAILED
Monday, February 8, 2021SUSPENSION INQUIRY WRITTEN
Friday, January 29, 2021LIE CHECKED SUSP - TO ATTY FOR ACTION
Thursday, July 23, 2020REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, January 21, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, January 21, 2020LETTER OF SUSPENSION E-MAILED
Tuesday, January 21, 2020SUSPENSION LETTER WRITTEN
Thursday, January 2, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 2, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 2, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, December 26, 2019TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, December 20, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, December 20, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 10, 2019NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, July 10, 2019INQUIRY TO SUSPENSION E-MAILED
Wednesday, July 10, 2019SUSPENSION INQUIRY WRITTEN
Wednesday, July 3, 2019LIE CHECKED SUSP - TO ATTY FOR ACTION
Thursday, January 3, 2019NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, January 3, 2019LETTER OF SUSPENSION E-MAILED
Thursday, January 3, 2019SUSPENSION LETTER WRITTEN
Friday, December 21, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 21, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 21, 2018ASSIGNED TO LIE
Tuesday, December 18, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 18, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 18, 2018NON-FINAL ACTION E-MAILED
Monday, June 18, 2018NON-FINAL ACTION WRITTEN
Tuesday, June 12, 2018ASSIGNED TO EXAMINER
Friday, March 9, 2018NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, March 8, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, March 3, 2018NEW APPLICATION ENTERED IN TRAM